Uploaded July 2026 | Updated November 2026, 3 days ago
Are GLP-1 drugs like Ozempic and Mounjaro cheating? Dr. Jordan Feigenbaum and Dr. Austin Baraki explain what GLP-1 and GLP-1/GIP medications actually do in the brain's appetite centers, what the STEP 1 (semaglutide, about 15 percent) and SURMOUNT-1 (tirzepatide, about 21 percent) trials showed versus lifestyle alone, and the benefits beyond the scale for sleep apnea, fatty liver, heart failure, and kidney disease.
Timestamps
0:00 Are GLP-1s 'cheating'? What the drugs actually do
0:21 How GLP-1 drugs act on the brain's appetite centers
1:06 GLP-1 and GIP: how the newer dual agonists work
1:24 The STEP 1 trial: about 15% weight loss on semaglutide
1:44 Why lifestyle alone rarely reaches 15%
2:35 SURMOUNT-1: tirzepatide and about 21% weight loss
3:53 GLP-1 benefits beyond the scale
4:37 Which conditions improve: sleep apnea, fatty liver, heart, kidney
5:22 Protecting muscle and lean mass on GLP-1s
7:47 Why the willpower argument dissolves
9:13 'You're taking the easy way out': a real clinic conversation
11:05 Do you have to take GLP-1s forever?
Resources
Barbell Medicine coaching and templates: barbellmedicine.com
Plus podcast subscription: barbellmedicine.com/shop/subscriptions/plus-podcast-subscription
Barbell Medicine Premium: barbellmedicine.com/shop/subscriptions/barbell-medicine-premium
Signal (book pre-order): barbellmedicine.com/shop/learning/signal
Studies referenced in this segment:
1. Morton RW, Murphy KT, McKellar SR, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. Br J Sports Med. 2018;52(6):376-384. doi.org/10.1136/bjsports-2017-097608
2. Mechanisms of GLP-1 receptor agonist-induced weight loss: a review of central and peripheral pathways (hypothalamic arcuate nucleus and brainstem area postrema). Am J Med. 2025. sciencedirect.com/science/article/pii/S0002934325000592
3. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. doi.org/10.1056/NEJMoa2032183
4. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. doi.org/10.1056/NEJMoa2206038
5. Grannell A, Fallon F, Al-Najim W, le Roux C. Obesity and responsibility: is it time to rethink agency? Obes Rev. 2021;22(8):e13270. doi.org/10.1111/obr.13270
Are GLP-1 drugs like Ozempic and Mounjaro cheating? Dr. Jordan Feigenbaum and Dr. Austin Baraki explain what GLP-1 and GLP-1/GIP medications actually do in the brain's appetite centers, what the STEP 1 (semaglutide, about 15 percent) and SURMOUNT-1 (tirzepatide, about 21 percent) trials showed versus lifestyle alone, and the benefits beyond the scale for sleep apnea, fatty liver, heart failure, and kidney disease.
Timestamps
0:00 Are GLP-1s 'cheating'? What the drugs actually do
0:21 How GLP-1 drugs act on the brain's appetite centers
1:06 GLP-1 and GIP: how the newer dual agonists work
1:24 The STEP 1 trial: about 15% weight loss on semaglutide
1:44 Why lifestyle alone rarely reaches 15%
2:35 SURMOUNT-1: tirzepatide and about 21% weight loss
3:53 GLP-1 benefits beyond the scale
4:37 Which conditions improve: sleep apnea, fatty liver, heart, kidney
5:22 Protecting muscle and lean mass on GLP-1s
7:47 Why the willpower argument dissolves
9:13 'You're taking the easy way out': a real clinic conversation
11:05 Do you have to take GLP-1s forever?
Resources
Barbell Medicine coaching and templates: barbellmedicine.com
Plus podcast subscription: barbellmedicine.com/shop/subscriptions/plus-podcast-subscription
Barbell Medicine Premium: barbellmedicine.com/shop/subscriptions/barbell-medicine-premium
Signal (book pre-order): barbellmedicine.com/shop/learning/signal
Studies referenced in this segment:
1. Morton RW, Murphy KT, McKellar SR, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. Br J Sports Med. 2018;52(6):376-384. doi.org/10.1136/bjsports-2017-097608
2. Mechanisms of GLP-1 receptor agonist-induced weight loss: a review of central and peripheral pathways (hypothalamic arcuate nucleus and brainstem area postrema). Am J Med. 2025. sciencedirect.com/science/article/pii/S0002934325000592
3. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. doi.org/10.1056/NEJMoa2032183
4. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. doi.org/10.1056/NEJMoa2206038
5. Grannell A, Fallon F, Al-Najim W, le Roux C. Obesity and responsibility: is it time to rethink agency? Obes Rev. 2021;22(8):e13270. doi.org/10.1111/obr.13270








![Where did the advice to not lift heavy weights come from?
Nearly every warning youve heard about lifting weights was written down before anybody checked it. We trace where those warnings came from, starting with a Harvard student in 1854 and ending with a curve on a graph thats being used today to argue you can lift too much.
Along the way: the men who built themselves with barbells and then sold the public five-pound dumbbells, because iron was expensive to mail and a booklet cost pennies. The muscle-bound myth, which nobody could define when a graduate student surveyed 45 physiologists about it. The 1961 report that took the deep squat out of every branch of the American military, measured with a device its author built himself and never validated. The claim that lifting stunts a childs growth, which no professional body ever actually made. And the argument women got, which was never about injury at all.
Timestamps:
• 0:00 Intro
• 2:33 2,500 years of people picking up heavy things
• 7:24 George Windship and the Health Lift
• 10:56 Blaikies truck horse and the muscle-bound myth
• 14:59 Bernarr Macfadden
• 19:39 Charles Atlas and Dynamic Tension
• 27:01 Carl Klein, a homemade device, and the parallel squat
• 30:57 Thomas Delorme and three sets of ten
• 35:20 Kids, growth plates, and where the stunting idea came from
• 41:43 Women, youll get bulky, and Dudley Sargent in 1912
• 50:05 Pregnancy, from 1949 to a 2025 barbell study
• 53:40 The pattern, and the curve on next weeks graph
Resources:
Buy the book, Signal: https://www.barbellmedicine.com/shop/learning/signal/
New Barbell Medicine Hybrid 5K and 10K Run + Lift Programs (https://www.barbellmedicine.com/shop/training-templates/endurance/hybrid-5k-10k/)
Barbell Medicine coaching and templates: https://www.barbellmedicine.com
1. Downs DS, Chasan-Taber L, Evenson KR, Leiferman J, Yeo S. Physical activity and pregnancy: past and present evidence and future recommendations. Res Q Exerc Sport. 2012;83(4):485-502. doi:10.1080/02701367.2012.10599138. PMID 23367811.
2. McMurray RG, Mottola MF, Wolfe LA, Artal R, Millar L, Pivarnik JM. Recent advances in understanding maternal and fetal responses to exercise. Med Sci Sports Exerc. 1993;25(12):1305-1321. PMID 8107536.
3. Smith KM, Campbell CG. Physical activity during pregnancy: impact of applying different physical activity guidelines. J Pregnancy. 2013;2013:165617. doi:10.1155/2013/165617. PMID 23476778.
4. American College of Obstetricians and Gynecologists. Physical activity and exercise during pregnancy and the postpartum period. ACOG Committee Opinion No. 804. Obstet Gynecol. 2020;135(4):e178-e188. doi:10.1097/AOG.0000000000003772. PMID 32217980.
5. American Academy of Pediatrics Committee on Sports Medicine and Fitness. Strength training by children and adolescents. Pediatrics. 2001;107(6):1470-1472. doi:10.1542/peds.107.6.1470. PMID 11389279.
6. Stricker PR, Faigenbaum AD, McCambridge TM; Council on Sports Medicine and Fitness. Resistance training for children and adolescents. Pediatrics. 2020;145(6):e20201011. doi:10.1542/peds.2020-1011. PMID 32457216.
7. Gardiner EN. Athletics of the Ancient World. Clarendon Press; 1930:54. See also Gardiner EN. Olympia: Its History and Remains. Clarendon Press; 1925.
8. Heffernan C. The Bybon stone and ancient strength. Physical Culture Study. 2021. Accessed September 2026. https://physicalculturestudy.com.
9. Pausanias. Description of Greece. 6.14.5. Jones WHS, trans. Loeb Classical Library. Harvard University Press.
10. Quintilian. Institutio Oratoria. 1.9.5. Butler HE, trans. Loeb Classical Library. Harvard University Press.
11. Heffernan C. Milo of Croton and the invention of progressive overload. Physical Culture Study. 2026. Accessed September 2026. https://physicalculturestudy.com. See also H.J. Lutcher Stark Center for Physical Culture and Sports, University of Texas at Austin, Milo Bar-Bell Company holdings.
12. Liddell HG, Scott R. A Greek-English Lexicon. 9th ed. Clarendon Press; entry γυμνάσιον. Thucydides. History of the Peloponnesian War. 1.6. Crawley R, trans.
13. Tomlinson RA. Gymnasium. In: Oxford Classical Dictionary. Oxford University Press; 2015. doi:10.1093/acrefore/9780199381135.013.2963. See also Stavrou D. The Greek Gymnasium [thesis]. University of Leicester; 2016:38.
14. Xenophon. Constitution of the Lacedaimonians. 1.4. Marchant EC, trans. Loeb Classical Library. Harvard University Press.
15. Plutarch. Life of Lycurgus. 14. Perrin B, trans. Loeb Classical Library. Harvard University Press.
16. Ollier F. Le Mirage Spartiate. Vols 1-2. Boccard; 1933-1943. Discussed in Rahe PA. The Grand Strategy of Classical Sparta. Yale University Press; 2016. See also Christesen P. Utopia on the Eurotas: Economic Aspects of the Spartan Mirage. In: Powell A, Hodkinson S, eds. Sparta: The Body Politic. Classical Press of Wales; 2010.
17. Pausania... Where did the advice to not lift heavy weights come from?](https://i.ytimg.com/vi/l9qk8SsQYh0/mqdefault.jpg)

